B. Wiedenmann

Original article Diagnosis of neuroendocrine tumours by retrospective image (2008)

H. Amthauer, H. Amthauer, J. Ruf, M. Böhmig, E. Lopez-hänninen, T. Rohlfing, ...

Abstract. This study evaluated the use of image fusion in the preoperative staging of neuroendocrine tumors (NET) of the pancreas and the gastrointestinal tract (GIT). Thirty-eight patients suffering...

Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathway (2008)

Göncz, E., Strowski, M. Z., Grötzinger, C., Nowak, K. W., Kaczmarek, P., Sassek, M., ...

A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer (2007)

Thomas, AL, Trarbach, T, Bartel, C, Laurent, D, Henry, A, Poethig, M, ...

Background: This open-label, phase IB study was undertaken to determine the safety/toxicity profile and recommended dose of oral once-daily PTK787/ZK 222584 (PTK/ZK) combined with...

EGR-1 and CREB are target molecules for orexin-A dependent inhibition of glucagon gene expression (2007)

Göncz, E., Grötzinger, C., Mergler, S., El-Zayat, B. F., Theodoropoulou, M., Stalla, G. K., ...

A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer (2007)

Thomas, AL, Trarbach, T, Bartel, C, Laurent, D, Henry, A, Poethig, M, ...

Background: This open-label, phase IB study was undertaken to determine the safety/toxicity profile and recommended dose of oral once-daily PTK787/ZK 222584 (PTK/ZK) combined with...

A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer (2007)

Thomas, AL, Trarbach, T, Bartel, C, Laurent, D, Henry, A, Poethig, M, ...

Background: This open-label, phase IB study was undertaken to determine the safety/toxicity profile and recommended dose of oral once-daily PTK787/ZK 222584 (PTK/ZK) combined with...

Orexin-A inhibits glucagon secretion and gene expression by foxo1 dependant pathway (2006)

Göncz, E., Grötzinger, C., Mergler, S., El-Zayat, B. F., Theodoropoulou, M., Stalla, G. K., ...

EGR-1 and CREB are target molecules for orexin-A dependant inhibition of glucagon gene expression (2006)

Grotzinger, C., Goncz, E., Mergler, S., Eichhorn, I., Theodoropoulou, M., Stalla, G. K., ...

Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways (2006)

Grabig, A, Paclik, D., Guzy, C., Dankof, A., Baumgart, D. C., Erckenbrecht, J., ...

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system (2004)

Öberg, K., Kvols, L., Caplin, M., Delle Fave, G., De Herder, W., Rindi, G., ...

This consensus report gives a detailed description of the use of somatostatin analogs in the management of neuroendocrine tumors of the gastroenteropancreatic system. As background information we...

Original article DOI: 10.1093/annonc/mdh216 (2003)

K. Öberg, L. Kvols, M. Caplin, G. Delle Fave, W. De Herder, G. Rindi, ...

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

Complication of Waldenströem’s macroglobulinaemia following ERCP

Pascu, M, Hanke, B, Wiedenmann, B, Martens, F, Dignass, A U

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells

Baumgart, D C, Metzke, D, Schmitz, J, Scheffold, A, Sturm, A, Wiedenmann, B, ...

Background: Breakdown of tolerance against the commensal microflora is believed to be a major factor in the pathogenesis of inflammatory bowel disease (IBD). Dendritic cells (DC) have been implicated...

Postprandial abdominal pain, megaloblastic anaemia, and severe weight loss in an 80 year old man

Dignass, A U, Pascu, M E, Roznowski, A B, Wiedenmann, B

A frequent keratin 8 p.L227L polymorphism, but no point mutations in keratin 8 and 18 genes, in patients with various liver disorders

Hesse, M, Berg, T, Wiedenmann, B, Spengler, U, Woitas, R, Magin, T

Keratin 8 Y54H and G62C mutations are not associated with liver disease

Halangk, J, Berg, T, Puhl, G, Mueller, T, Nickel, R, Kage, A, ...

Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis

Baumgart, D C, Sturm, A, Wiedenmann, B, Dignass, A U

Anti‐ghrelin Spiegelmer NOX‐B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats

Kobelt, P, Helmling, S, Stengel, A, Wlotzka, B, Andresen, V, Klapp, B F, ...

Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasis

Schulz, P, Scholz, A, Rexin, A, Hauff, P, Schirner, M, Wiedenmann, B, ...

Functional inactivation of the tumour suppressor protein p16INK4a constitutes a key event in the multistep process of pancreatic ductal cell transformation. However, the significance of p16...

Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor.

Männel, D. N., Kist, A., Ho, A. D., Räth, U., Reichardt, P., Wiedenmann, B., ...

Tumour necrosis factor (TNF) has been found to be an important immunomodulator. Among other functions TNF activates natural killer (NK) cells and stimulates monocytes/macrophages in an autocrine...